Biokeys Pharmaceuticals Inc. Announces That It Has Initiated Manufacturing of Its Colorectal Cancer Drug for Phase II Human Trials; Company Seeks to Replicate Success of Swedish Trials.
Linked as:
Extract
Biokeys Pharmaceuticals Inc. Announces That It Has Initiated Manufacturing of Its Colorectal Cancer Drug for Phase II Human Trials; Company Seeks to Replicate Success of Swedish Trials.
Business Editors/Health/Medical Writers
BIOWIRE2K SAN DIEGO--(BUSINESS WIRE)--June 5, 2003 Biokeys Pharmaceuticals Inc. (OTCBB:BKYS), a biopharmaceutical company special...See the full content of this document
Sponsored links
